Rafarma Pharmaceuticals, Inc. logo
Rafarma Pharmaceuticals (RAFA) Announces New President as Part of Pending Acquisition of Majority Interest
30 juil. 2014 14h40 HE | Rafarma Pharmaceuticals, Inc.
MOSCOW, July 30, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc. (Pink Sheets:RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
30 juin 2014 14h05 HE | Elite Pharmaceuticals, Inc.
Revenues Increase by 35%, Product Development Accelerating Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT NORTHVALE, N.J., June 30, 2014 (GLOBE NEWSWIRE) -- Elite...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Results of 2014 Annual Meeting of Shareholders
23 mai 2014 11h08 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 23, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) today announced the voting results of matters considered during the...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
14 févr. 2014 09h49 HE | Elite Pharmaceuticals, Inc.
Revenues Increase by 154%, Product Development Accelerating Conference Call Scheduled for Tuesday, February 18 at 3:00 PM ET NORTHVALE, N.J., Feb. 14, 2014 (GLOBE NEWSWIRE) -- Elite...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
10 févr. 2014 15h26 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Bridge Loan Facility
16 oct. 2013 07h45 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a credit line agreement ("Credit Line") with Nasrat...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
08 oct. 2013 07h45 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a Manufacturing and License Agreement ("Agreement")...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride
18 sept. 2013 07h51 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 18, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the initial shipment of naltrexone hydrochloride 50 mg tablets...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
03 sept. 2013 09h46 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014
14 août 2013 16h29 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...